Hello blog!

Erectile Dysfunction Can Now Be Treated with a Cream

A totally new kind of erectile dysfunction drug is to be introduced on the Eastern markets by a UAE-based pharmaceutical company, giving men more options to deal with impotence.

Vitaros

Vitaros(R), an ED drug by Elis, a UAE-based pharmaceutical company, will be presented to the Government and pharmacists in the Middle East, Africa and CIS countries. This drug is already approved in Canada and several other countries as the first topical ED treatment. The major advantage of this drug over other oral and other ED therapies is its form. Vitaros(R) is a cream that is applied directly to the penis, rather than a pill that takes longer to absorb. Also, it has less side effects and gives men more choices.

Commenting on the introduction of the drug onto the new markets, Mr. Assouma of Elis, said: “Because of Elis’ proven marketing strategies and the patient responses we’ve already experienced as part of our sampling program, we anticipate strong sales of Vitaros(R) in this region, where the total market for erectile dysfunction drugs is more than $100 million per year.”

Impotence Might Cause Migraines, Research Found

Scientists from Taiwan found out that men suffering from erectile dysfunction are more likely to be diagnosed with migraines than men of good sexual health.

Migraines and ED

According to the study performed by scientists from National Taiwan University’s College of Medicine, erectile dysfunction is linked to migraines.

Dr. Chao-Yuan Huang, the author of the study, and his colleagues studies 23,000 men of whom 25% had problems getting and maintaining erection. Of them, 4.25% were already diagnosed with migraine. Other factors that increase the risk of developing this disorder included age, heart problems and diabetes. As a result, scientists found out that men in the ED-group are 1.63 times more likely to suffer from migraines than men of sound sexual health.

American scientists found the study by Taiwanese colleagues unique and said that further research in this area is needed to learn more about male sexual health and migraines. As such, Ege Serefoglu, from the urology department at Tulane University School of Medicine, said they findings “need to be confirmed by other countries, other researchers, before we can really include migraine as a risk factor of erectile dysfunction or vice versa.”

Israeli ED Treatment Technique Now Offered in the UK

Researchers from Haifa’s Rambam Medical Centre have recently developed a revolutionary technology for treatment of erectile dysfunction that is now spreading worldwide.

Rambam Medical Centre Doctors

Probably this is due to the successful clinical trials, to the publications in three major medical journals or to the efficiency and pain-free technique of the treatment. The experimental treatment uses low-intensity shockwaves that stimulate the blood flow in penis.

The non-invasive procedure is not being offered not only in Israel but also in Scotland, UK by Spire Murrayfield Hospital. It is being offered in the form of regular visits to the clinic (12 visits over 9 weeks) at a low price of just 1,500 pounds.

The technique is being considered an alternative to traditional injections and medications like Cialis or Viagra.

Commenting on the success, Professor Yoram Vardi of Rambam Medical Centre, said: “During the past three years we have encountered a slow but steady shift from scepticism to gaining more and more encouragement and support from the medical community.”

Roland Donat of Spire Murrayfield Hospital, in his turn, said that “This treatment is a revolution in the management of erectile dysfunction. For the first time, we are able to cure some patients with [the condition] rather than treat them symptomatically.”

Sexual Problems Might Be Caused by Independent Relations

The better and the closer the relations between the partners are, the less sexual problems they face.

Relations

Scientists from Australian Deakin University performed a research that showed a close link between sexual issues and relationship between partners.

The research, performed by Christina Stefanou and professor Marita McCabe of Deakin’s School of Psychology among 127 people revealed that those who value intimacy and fear rejection have less sexual problems. In particular, women have less problems with sexual arousal, lubrication and orgasm, while men do not suffer from erectile dysfunction and ejaculation problems. In contrast, those who fell uncomfortable with closeness more often face erectile and sexual dysfunction and dissatisfaction.

Commenting on the findings, scientists said: “Rather than simply treating the symptoms of sexual dysfunction, treatment strategies may be more effective if they considered the psychological characteristics that impact on sexual behavior within relationships.”

You can take part in the research by Stefanou and McCabe by completing an online questionnaire.

Vivus Reports Positive Results of Avanafil Trials

The manufacturer of the new erectile dysfunction drug, Avanafil, recently posted positive results from the drug’s clinical trials.

Avanafil

Last Tuesday, Vivus, a pharmaceutical company, posted positive results from a trial of its new erectile dysfunction drug that is currently undergoing the review of the US Food and Drug Administration.

Avanafil, the experimental impotence drug, was proved to help 71% of patients to start the sexual intercourse within 15 minutes and after 6 hours after dosing.

In the 80% of cases, the 200-mg dose was sufficient for men suffering from ED, to get and maintain healthy erection.

The results of the clinical trial were published in the Journal of Sexual Medicine.

Commenting on the findings, Irwin Goldstein, the investigator of Avanafil, said: “While PDE-5 inhibitors are currently used as first-line therapy for treatment of erectile dysfunction in the general population, what’s new and novel about avanafil is that it has a fast onset of action and high selectivity.”

The drug will appear in US pharmacies provided it gets the approval from US FDA.

Physical Activity Helps Prevent Erectile Dysfunction

American scientists found out that men with a sedentary lifestyle are more prone to sexual problems including erectile dysfunction than those who live active lives.

Sports enhance sexual function

According to the latest study published in the Journal of Sexual Medicine, men engaged into physical activity are less prone to erectile dysfunction than those who are inactive.

The study was performed among men aged 18 to 40. The participants of the study took part in 2 experiments: the Paffenbarger Physical Activity Questionnaire and the International Index of Erectile Function.

Both tests clearly showed that men under 40, who exercised, have improved results as compared to those over 40 who lived sedentary lives.

Commenting on the findings, Dr. Wayland Hsiao, assistant professor of urology at Emory University School of Medicine in Atlanta, GA, said: “We hope that early screening for ED may be a gateway issue to help motivate young men to live healthily on a consistent basis so that they can possibly avoid health issues associated with a sedentary lifestyle, such as diabetes and cardiovascular disease.”

A number of other studies that evaluate the correlation between sexual function and lifestyle have been published earlier by various researchers.

Viaguara Trademark Cannot be Registered in the EU

The European high court ruled that a popular energy drink known as Viaguara has no right to register its trademark in the EU.

Viaguara Energy Drink

Recently, the confusion caused by the producer of an energy drink Viaguara was averted as the EU High Court made the decision.

The company was refused the right to register a trademark for its Viaguara energy and alcoholic drink. The EU High Court ruled that there are several reasons for that.

First, the Viagura name gives the producer an opportunity “to take unfair advantage of the distinctive character or repute of the trademark Viagra.”

Second, Viagra is a medical drug used to treat erectile dysfunction. It is a prescription drug, meaning that it can be sold only to those patients who have been prescribed to take Viagra by a doctor. Any confusion related to the name of the drug might have serious medical consequences. “Even if the non-alcoholic drinks concerned do not actually have the same benefits as a drug to treat erectile dysfunction, the consumer will be inclined to buy them thinking that he will find similar qualities, such as an increase in libido,” said the representative of the EU High Court.

The manufacturer of Viagra, Pfizer, warmly welcomed the court ruling.